Discovery of Novel Neuraminidase Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of Novel Neuraminidase Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay

Published:2019-11-25 Issue:12 Volume:10 Page:1667-1673
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Yu Rao¹,Cheng Li Ping¹^ORCID,Li Meng¹,Pang Wan¹

Affiliation:

1. School of Chemical and Environmental Engineering, Shanghai Institute of Technology, Shanghai 201418, China

Funder

Natural Science Foundation of Shanghai

Shanghai Municipal Education Commission

Collaborative Innovation Fund

Middle and Youth Teachers Scientific and Technological Talents Developing Fund

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.9b00447

Reference24 articles.

1. Hierarchy among Viral RNA (vRNA) Segments in Their Role in vRNA Incorporation into Influenza A Virions

2. Structures of influenza A proteins and insights into antiviral drug targets

3. Preventing and treating influenza

4. Antiviral therapy of influenza

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Efforts in Identification of Privileged Scaffolds as Antiviral Agents;Chemistry & Biodiversity;2023-09-25

2. Study on the Interaction between Silibinin and Neuraminidase;Current Pharmaceutical Design;2023-02

3. Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors;Bioorganic & Medicinal Chemistry;2022-03

4. Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of “Different Diseases with the Same Treatment” Based on Network Pharmacology;Evidence-Based Complementary and Alternative Medicine;2022-02-08

5. Design, synthesis and biological evaluation of oxalamide derivatives as potent neuraminidase inhibitors;New Journal of Chemistry;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3